PTC Therapeutics (United States)
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for PTC Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
50%
Total
Publications
416
Total Open
Publications
210
Total
Citations
12K
Open Access
Percentage
50%
Total
Publications
416
Total Open
Publications
210
Total
Citations
12K
Breakdown
Publisher Open
15%
Both
27%
Other Platform Open
9%
Closed
49%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
46
Hybrid 50%
87
No Guarantees 23%
39
Other Platform Open
Domain 87%
129
Institution 16%
24
Other Internet 13%
19
Public 10%
15
Preprint 7%
11
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 130 |
Europe PMC | Domain | 65 |
University College London - UCL Discovery | Institution | 19 |
DOI | Other Internet | 14 |
Semantic Scholar | Public | 9 |
Figshare | Public | 9 |
California Digital Library - eScholarship | Other Internet | 8 |
bioRxiv | Preprint | 8 |
University of Massachusetts Medical School - eScholarship@UMMS | Institution | 5 |
University of California - eScholarship University of California | Institution | 5 |